These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 25088441

  • 21. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor.
    Laguna P, Klukowska A.
    Haemophilia; 2005 Jan; 11(1):2-4. PubMed ID: 15660981
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Illustrated operative management of spontaneous bleeding and compartment syndrome of the lower extremity in a patient with acquired hemophilia A: a case report.
    Jentzsch T, Brand-Staufer B, Schäfer FP, Wanner GA, Simmen HP.
    J Med Case Rep; 2014 Apr 30; 8():132. PubMed ID: 24886030
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cost effectiveness of prophylactic treatment with activated prothrombin complex concentrate in a patient with inhibitor-positive hemophilia A.
    Nakamura S, Morimoto A, Oh Y, Hayase T, Kashii Y, Gunji Y, Momoi MY.
    Blood Coagul Fibrinolysis; 2012 Apr 30; 23(3):235-7. PubMed ID: 22322137
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of algorithms for the treatment of problem bleeding episodes in patients with hemophilia having inhibitors.
    Young G, Teitel J, d'Oiron R, Leissinger C, Berntorp E.
    Clin Appl Thromb Hemost; 2015 Jan 30; 21(1):10-8. PubMed ID: 25343956
    [Abstract] [Full Text] [Related]

  • 27. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J, Goral A, Paluszkiewicz P, Przesmycki K, Kotarski J.
    Obstet Gynecol; 2003 Jun 30; 101(6):1172-3. PubMed ID: 12798520
    [Abstract] [Full Text] [Related]

  • 28. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Gielen-Wijffels SE, van Mook WN, Ramsay G.
    Ned Tijdschr Geneeskd; 2003 Mar 01; 147(9):419. PubMed ID: 12661464
    [No Abstract] [Full Text] [Related]

  • 29. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M, Manonai J, Herabutya Y, Chuncharunee S.
    J Med Assoc Thai; 2007 May 01; 90(5):977-81. PubMed ID: 17596055
    [Abstract] [Full Text] [Related]

  • 30. Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008).
    Nakar C, Cooper DL, DiMichele D.
    Haemophilia; 2010 Jul 01; 16(4):625-31. PubMed ID: 20158526
    [Abstract] [Full Text] [Related]

  • 31. [Acquired hemophilia presenting as gross hematuria and perineal subcutaneous hemorrhage after prostate biopsy: a case report].
    Kimura H, Uegaki M, Aoyama T, Miyoshi T, Nagai K, Hashimura T.
    Hinyokika Kiyo; 2013 May 01; 59(5):305-8. PubMed ID: 23719140
    [Abstract] [Full Text] [Related]

  • 32. [Acquired hemophilia A as a cause of postoperative bleeding].
    Leimkühler K, Bach F, Kobert K, Korth M, Schmidt B, Kulbe C, Gummelt I, Mertzlufft F.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 May 01; 38(5):359-65. PubMed ID: 12712401
    [Abstract] [Full Text] [Related]

  • 33. Recombinant activated factor VII for hemoperitoneum after transjugular intrahepatic portosystemic shunt.
    Biancofiore G, Bindi LM, Cioni R, Cicorelli A, Filipponi F.
    Blood Coagul Fibrinolysis; 2010 Sep 01; 21(6):611. PubMed ID: 20703105
    [No Abstract] [Full Text] [Related]

  • 34. Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors.
    Blatny J, Kohlerova S, Zapletal O, Fiamoli V, Penka M, Smith O.
    Haemophilia; 2008 Sep 01; 14(5):1140-2. PubMed ID: 18540894
    [No Abstract] [Full Text] [Related]

  • 35. Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
    Franchini M, Capra F, Capelli C, de Maria E, Lippi G, Gandini G.
    Haematologica; 2001 Apr 01; 86(4):E12. PubMed ID: 11325664
    [No Abstract] [Full Text] [Related]

  • 36. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
    Kawasaki Y, Saeki N, Kawamoto M, Yuge O, Fujii T.
    Masui; 2005 Aug 01; 54(8):926-8. PubMed ID: 16104555
    [Abstract] [Full Text] [Related]

  • 37. Case report: lumbar artery bleeding as a complication of percutaneous nephrostomy in a patient with coagulopathy.
    Chan PN, Wong KT, Lee SF, Yu SC.
    Br J Radiol; 2004 Oct 01; 77(922):878-80. PubMed ID: 15483003
    [Abstract] [Full Text] [Related]

  • 38. Experience of recombinant activated factor VII usage during surgery in patients with haemophilia with inhibitors.
    Polyanskaya T, Zorenko V, Karpov E, Sampiev M, Mishin G, Vasiliev D.
    Haemophilia; 2012 Nov 01; 18(6):997-1002. PubMed ID: 22672066
    [Abstract] [Full Text] [Related]

  • 39. Prophylaxis in congenital hemophilia with inhibitors: the role of recombinant activated factor VII.
    Franchini M, Manzato F, Salvagno GL, Montagnana M, Zaffanello M, Lippi G.
    Semin Thromb Hemost; 2009 Nov 01; 35(8):814-9. PubMed ID: 20169518
    [Abstract] [Full Text] [Related]

  • 40. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.
    Smith MP, Ludlam CA, Collins PW, Hay CR, Wilde JT, Grigeri A, Melsen T, Savidge GF.
    Thromb Haemost; 2001 Oct 01; 86(4):949-53. PubMed ID: 11686351
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.